Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
American Heart Journal|January 5, 2002
Reduced inhibition by abciximab in platelets with the PlA2 polymorphismGuy L Wheeler, Gregory A Braden, Paul F Bray, et al.Journal of Interventional Cardiology|March 30, 2007
Mechanism of luminal gain with plaque excision in atherosclerotic coronary and peripheral arteries: assessment by histology and intravascular ultrasoundFumiaki Ikeno, Gregory A Braden, Hideaki Kaneda, et al.Journal of the American College of Cardiology|July 10, 2002
Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularizationRobert J Applegate, Mark A Grabarczyk, William C Little, et al.American Heart Journal|March 30, 2002
The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapyGuy L Wheeler, Gregory A Braden, Steven R Steinhubl, et al.Thrombosis Research|March 26, 2004
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levelsJacqueline Saw, Dean J Kereiakes, Kenneth W Mahaffey, et al.The American Journal of Cardiology|April 15, 2004
Final results of the ReoPro readministration registryJean-Pierre Dery, Gregory A Braden, A Michael Lincoff, et al.Journal of the American College of Cardiology|September 19, 2003
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) StudyDavid J Moliterno, James B Hermiller, Dean J Kereiakes, et al.Pageof 1